177 related articles for article (PubMed ID: 12858327)
1. Tianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder.
Niederhofer H; Staffen W; Mair A
Hum Psychopharmacol; 2003 Jul; 18(5):389-93. PubMed ID: 12858327
[TBL] [Abstract][Full Text] [Related]
2. Clonidine treatment of hyperactive and impulsive children with autistic disorder.
Jaselskis CA; Cook EH; Fletcher KE; Leventhal BL
J Clin Psychopharmacol; 1992 Oct; 12(5):322-7. PubMed ID: 1479049
[TBL] [Abstract][Full Text] [Related]
3. St John's Wort treating patients with autistic disorder.
Niederhofer H
Phytother Res; 2009 Nov; 23(11):1521-3. PubMed ID: 19274686
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.
King BH; Wright DM; Handen BL; Sikich L; Zimmerman AW; McMahon W; Cantwell E; Davanzo PA; Dourish CT; Dykens EM; Hooper SR; Jaselskis CA; Leventhal BL; Levitt J; Lord C; Lubetsky MJ; Myers SM; Ozonoff S; Shah BG; Snape M; Shernoff EW; Williamson K; Cook EH
J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):658-65. PubMed ID: 11392343
[TBL] [Abstract][Full Text] [Related]
5. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
[TBL] [Abstract][Full Text] [Related]
6. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
Baghdadli A; Gonnier V; Aussilloux C
Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism.
Fankhauser MP; Karumanchi VC; German ML; Yates A; Karumanchi SD
J Clin Psychiatry; 1992 Mar; 53(3):77-82. PubMed ID: 1548248
[TBL] [Abstract][Full Text] [Related]
8. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
Wasserman S; Iyengar R; Chaplin WF; Watner D; Waldoks SE; Anagnostou E; Soorya L; Hollander E
Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983
[TBL] [Abstract][Full Text] [Related]
10. Neuropharmacologic treatment of bronchial asthma with the antidepressant tianeptine: a double-blind, crossover placebo-controlled study.
Lechin F; van der Dijs B; Orozco B; Jara H; Rada I; Lechin ME; Lechin AE
Clin Pharmacol Ther; 1998 Aug; 64(2):223-32. PubMed ID: 9728903
[TBL] [Abstract][Full Text] [Related]
11. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
[TBL] [Abstract][Full Text] [Related]
12. Guanfacine in children with autism and/or intellectual disabilities.
Handen BL; Sahl R; Hardan AY
J Dev Behav Pediatr; 2008 Aug; 29(4):303-8. PubMed ID: 18552703
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.
Kolmen BK; Feldman HM; Handen BL; Janosky JE
J Am Acad Child Adolesc Psychiatry; 1995 Feb; 34(2):223-31. PubMed ID: 7896655
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of transdermal secretin on behavior of children with autism.
Ratliff-Schaub K; Carey T; Reeves GD; Rogers MA
Autism; 2005 Jul; 9(3):256-65. PubMed ID: 15937041
[TBL] [Abstract][Full Text] [Related]
15. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
[TBL] [Abstract][Full Text] [Related]
16. Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents.
Hurwitz R; Blackmore R; Hazell P; Williams K; Woolfenden S
Cochrane Database Syst Rev; 2012 Mar; (3):CD008372. PubMed ID: 22419332
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone in autistic children: a double-blind and placebo-controlled study.
Campbell M; Anderson LT; Small AM; Locascio JJ; Lynch NS; Choroco MC
Psychopharmacol Bull; 1990; 26(1):130-5. PubMed ID: 2196621
[TBL] [Abstract][Full Text] [Related]
18. Naltrexone in young autistic children: replication study and learning measures.
Kolmen BK; Feldman HM; Handen BL; Janosky JE
J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1570-8. PubMed ID: 9394942
[TBL] [Abstract][Full Text] [Related]
19. Multisite, double-blind, placebo-controlled trial of porcine secretin in autism.
Owley T; McMahon W; Cook EH; Laulhere T; South M; Mays LZ; Shernoff ES; Lainhart J; Modahl CB; Corsello C; Ozonoff S; Risi S; Lord C; Leventhal BL; Filipek PA
J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1293-9. PubMed ID: 11699803
[TBL] [Abstract][Full Text] [Related]
20. Tianeptine as a slightly effective therapeutic option for attention-deficit hyperactivity disorder.
Niederhofer H
Neuropsychobiology; 2004; 49(3):130-3. PubMed ID: 15034228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
